TNF and ovarian carcinoma: As shown in Figure 12, treatment with ICA-raw and ICA-Cubs can significantly increase the production of TNF-α within ovarian cancer cells, where the efficacy of the ICA-Cubs is significantly higher when compared with the ICA-raw treatment.